Cargando…

The Management of Type 2 Diabetic Patients with Hypoglycaemic Agents

Type 2 Diabetes Mellitus (T2DM) is characterized by chronic hyperglycemia with disturbance in carbohydrate, lipid, and protein metabolism due to insulin resistance and beta cell dysfunction. Epidemiological studies have confirmed a global pandemic of T2DM, which has created an enormous burden on soc...

Descripción completa

Detalles Bibliográficos
Autor principal:	Tsang, Man-Wo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scholarly Research Network 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356899/ https://www.ncbi.nlm.nih.gov/pubmed/22645689 http://dx.doi.org/10.5402/2012/478120

Ejemplares similares

Effect of oral hypoglycaemic agents on bone metabolism in patients with type 2 diabetes mellitus & occurrence of osteoporosis
por: Kumar, B. Siddhartha, et al.
Publicado: (2015)

Hypoglycaemic Molecules for the Management of Diabetes Mellitus from Marine Sources
por: Chellappan, Dinesh Kumar, et al.
Publicado: (2023)

Oral Hypoglycaemic Agents: The First Thirty Years
por: Nabarro, John D. N.
Publicado: (1992)

Conventional Hypoglycaemic Agents and the Risk of Lung Cancer in Patients with Diabetes: A Meta-Analysis
por: Wu, Ying, et al.
Publicado: (2014)

Design and Synthesis of Pyrazole-3-one Derivatives as Hypoglycaemic Agents
por: Datar, Prasanna A., et al.
Publicado: (2015)

Hypoglycaemic therapy in frail older people with type 2 diabetes mellitus—a choice determined by metabolic phenotype
por: Sinclair, Alan J., et al.
Publicado: (2022)

Hypoglycaemic treatment adherence and the association with psychological, self‐management and glycaemic characteristics in adults with type 1 diabetes
por: Martyn‐Nemeth, Pamela, et al.
Publicado: (2019)

New Hypoglycaemic Therapies
por: Gale, Edwin A M
Publicado: (2000)

Incidence of severe hypoglycaemic episodes in patients with type 2 diabetes in the Basque country: impact on healthcare costs
por: Alonso-Morán, Edurne, et al.
Publicado: (2015)

HYPOGLYCAEMIC ACTION OF MOMORDICA CHARANTIA IN NORMAL AND DIABETIC MICE
por: Kavimani, S., et al.
Publicado: (1997)

Evaluation of the hypoglycaemic and antioxidant effects of submerged Ganoderma lucidum cultures in type 2 diabetic rats
por: Huang, Chung-Hsiung, et al.
Publicado: (2020)

Beat it early: putative renoprotective haemodynamic effects of oral hypoglycaemic agents
por: Gnudi, Luigi, et al.
Publicado: (2016)

Occurrence of severe hypoglycaemic events among US youth and young adults with type 1 or type 2 diabetes
por: Saydah, Sharon, et al.
Publicado: (2019)

Interprofessional primary care electronic intervention to reduce hypoglycaemic agent use in high-risk veterans with diabetes
por: Upadhyay, Vaibhav, et al.
Publicado: (2018)

The oxidation and hypoglycaemic effect of sorafenib in streptozotocin-induced diabetic rats
por: Karbownik, Agnieszka, et al.
Publicado: (2020)

Diabetes treatment and hypoglycaemic episodes in elderly patients at nursing homes in Uppsala County
por: Walfridsson, Angelica, et al.
Publicado: (2016)

HYPOGLYCAEMIC PROPERTY OF SHILAJEET AND YASHADA BHASMA
por: Bharati,, et al.
Publicado: (1996)

YASADA BHASMA : AN EFFECTIVE HYPOGLYCAEMIC DRUG
por: Prasad, C.M., et al.
Publicado: (1989)

A comparison of the anti-diabetic potential of d-ribose-l-cysteine with insulin, and oral hypoglycaemic agents on pregnant rats
por: Osinubi, Abraham A.A., et al.
Publicado: (2018)

Hypoglycaemic and Antioxidant Effects of Propolis of Chihuahua in a Model of Experimental Diabetes
por: Rivera-Yañez, Nelly, et al.
Publicado: (2018)

Carvedilol prevents impairment of the counterregulatory response in recurrently hypoglycaemic diabetic rats
por: Farhat, Rawad, et al.
Publicado: (2021)

Impact of deintensifying hypoglycaemic drugs in older adults with type 2 diabetes: protocol for an emulation of a target trial
por: Christiaens, Antoine, et al.
Publicado: (2023)

Self-reported frequency and impact of hypoglycaemic events in insulin-treated diabetic patients in Austria
por: Weitgasser, Raimund, et al.
Publicado: (2014)

Correction to: The oxidation and hypoglycaemic effect of sorafenib in streptozotocin-induced diabetic rats
por: Karbownik, Agnieszka, et al.
Publicado: (2021)

Relationship of glycaemic control and hypoglycaemic episodes to 4‐year cardiovascular outcomes in people with type 2 diabetes starting insulin
por: Freemantle, N., et al.
Publicado: (2015)

The Management of Type 2 Diabetic Patients with Hypoglycemic Agents
por: Carnevale Schianca, G. P., et al.
Publicado: (2012)

Redefining diabetes mellitus treatments according to different mechanisms beyond hypoglycaemic effect
por: Nodari, Savina, et al.
Publicado: (2022)

The efficacy of dapagliflozin combined with hypoglycaemic drugs in treating type 2 diabetes mellitus: meta-analysis of randomised controlled trials
por: Sun, Yu-nan, et al.
Publicado: (2014)

Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study
por: Douros, Antonios, et al.
Publicado: (2018)

Hypoglycaemic events in patients with type 2 diabetes in the United Kingdom: associations with patient-reported outcomes and self-reported HbA1c
por: Mitchell, Beth D, et al.
Publicado: (2013)

A nine country study of the burden of non-severe nocturnal hypoglycaemic events on diabetes management and daily function
por: Brod, M, et al.
Publicado: (2013)

Assessing the economic value of maintained improvements in Type 1 diabetes management, in terms of HbA(1c), weight and hypoglycaemic event incidence
por: McEwan, P., et al.
Publicado: (2018)

A cost of illness study of hypoglycaemic events in insulin-treated diabetes in the Netherlands
por: de Groot, Saskia, et al.
Publicado: (2018)

Defining Potentially Inappropriate Prescriptions for Hypoglycaemic Agents to Improve Computerised Decision Support: A Study Protocol
por: Quindroit, Paul, et al.
Publicado: (2021)

Use of multiple antidiabetic medications in patients with diabetes and its association with hypoglycaemic events: a case-crossover study in Jordan
por: Naser, Abdallah Y, et al.
Publicado: (2018)

Studies on the Hypoglycæmic Effect of Tephrosia Purpurea Var. Pumila
por: Swift, H. B. N., et al.
Publicado: (1949)

Alteration of circulating platelet-related and diabetes-related microRNAs in individuals with type 2 diabetes mellitus: a stepwise hypoglycaemic clamp study
por: Eyileten, Ceren, et al.
Publicado: (2022)

Hypoglycaemic activity of biosynthesized copper oxide nanoparticles in alloxan‐induced diabetic Wister rats
por: Umar, Maimuna Bello, et al.
Publicado: (2023)

Anti-Inflammatory Properties In Vitro and Hypoglycaemic Effects of Phenolics from Cultivated Fruit Body of Phellinus baumii in Type 2 Diabetic Mice
por: Yang, Kai, et al.
Publicado: (2021)

Simultaneous Use of Stimulatory Agents to Enhance the Production and Hypoglycaemic Activity of Polysaccharides from Inonotus obliquus by Submerged Fermentation
por: Wang, Mengya, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j1h2qqdd35eoc6o6haf1c3bevo